info icon

Other histiocytosis syndromes

D3_HISTICYTSDROTH

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 D76.3
  • Cause of death: ICD-10 D76.3

2 out of 7 registries used, show all original rules.

44

4. Check minimum number of events

None

44

5. Include endpoints

None

44

6. Filter based on genotype QC (FinnGen only)

44

Control definitions (FinnGen only)

Control exclude
D3_BLOODOTHER

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D76
Name in latin
Alia syndromata histiocytotica

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 382 184 198
Only index persons 286 133 153
Unadjusted period prevalence (%)
Whole population 0.01 0.01 0.01
Only index persons 0.01 0.00 0.01
Median age at first event (years)
Whole population - 18.76 16.59
Only index persons 31.85 32.28 31.48

-FinnGen-

Key figures

All Female Male
Number of individuals 44 25 19
Unadjusted period prevalence (%) 0.01 0.01 0.01
Median age at first event (years) 47.16 52.32 40.37

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

No data available

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3023520) Reticulocytes [#/volume] in Blood
17
16
16.69
16.60
4.3
2.5
e9/l
75.1
75.9
0.02
11
11
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
19
25
12.62
14.82
4.8
4.6
u/l
199.3
235.1
1.33
19
25
(3004588) Protein electrophoresis panel - Serum or Plasma
14
17
11.61
11.28
3.1
1.2
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
8
0
+∞
8.60
1.6
0.0
u/ml
794.5
—
—
8
0
(42870588) Differential panel, method unspecified - Blood
28
114
5.00
6.39
13.3
5.9
—
—
—
0
0
(4035726)
14
37
5.08
5.30
2.2
1.5
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
7
5
16.24
4.74
1.3
1.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
7
5
16.24
4.74
1.3
1.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
8
10
9.46
4.26
1.8
1.3
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
19
76
3.64
4.06
5.8
4.6
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
14
46
4.00
3.95
1.6
1.4
titre
466.7
366.7
—
6
12
(3021440) Promyelocytes/100 leukocytes in Blood
11
30
4.56
3.92
10.2
7.3
%
0.0
0.1
—
5
13
(3044290) Cell count panel - Cerebral spinal fluid
6
5
13.57
3.88
1.2
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
9
17
6.35
3.74
1.4
1.2
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
30
167
3.50
3.72
9.0
9.9
mmol/l
1.2
1.2
0.05
21
145
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
7
9
8.98
3.71
1.9
3.2
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
11
33
4.11
3.46
10.2
6.8
%
1.6
0.4
—
5
14
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
6
7
9.67
3.37
1.2
1.4
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
10
29
4.17
3.27
11.2
6.7
%
0.4
0.3
—
5
9
(3025159) Blasts/100 leukocytes in Blood
10
29
4.17
3.27
9.1
7.4
%
0.2
0.0
—
5
12
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
6
8
8.45
3.16
1.2
1.3
mg/l
732.7
302.8
—
6
8
(3030905) Polymorphonuclear cells [#/volume] in Blood
5
5
11.03
3.05
4.6
6.6
e9/l
2.7
4.2
—
5
5
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
5
5
11.03
3.05
4.4
9.6
%
52.2
60.8
—
5
5
(3018418) pH of Serum or Plasma
19
95
2.76
2.61
7.0
3.9
ph
7.4
7.4
—
7
17
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
10
34
3.51
2.60
2.4
3.2
umol/l
3.6
7.9
—
10
29
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
7
16
4.98
2.59
4.9
1.1
g/l
0.2
0.2
—
7
16
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
6
12
5.60
2.49
2.5
1.1
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
9
28
3.77
2.47
13.7
14.6
mmol/l
11.6
8.1
—
9
28
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
5
8
6.87
2.43
2.0
1.1
g/l
0.0
0.0
—
5
8
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
5
8
6.87
2.43
1.2
1.4
e6/l
26.2
32.9
—
5
8
(40758558) Short blood count panel - Blood
18
92
2.62
2.33
9.6
4.4
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
5
9
6.10
2.27
1.6
1.4
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
6
15
4.45
2.12
3.3
26.4
%
94.7
91.5
—
6
15
(3002256) Pathology report gross observation
9
33
3.16
2.07
1.6
1.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
8
27
3.39
2.05
8.6
5.1
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
8
28
3.26
1.97
3.9
34.8
kpa
9.9
12.6
—
8
28
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
8
28
3.26
1.97
3.9
34.7
kpa
5.0
5.3
—
8
28
(3032080) INR in Blood by Coagulation assay
20
115
2.36
1.97
13.0
7.6
inr
1.2
1.2
—
9
28
(3037467) Urinalysis macro (dipstick) panel - Urine
33
241
2.48
1.81
5.7
3.8
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
16
86
2.35
1.80
6.9
4.1
estimate
0.0
0.0
—
9
34
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
5
13
4.19
1.76
1.8
1.3
—
—
—
0
0
(3000991) Gas panel - Venous blood
8
31
2.92
1.76
3.9
16.7
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
7
25
3.13
1.73
2.4
2.8
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
19
113
2.20
1.68
2.1
1.8
pmol/l
94.4
99.4
—
9
56
(3017143) Hepatitis C virus Ab [Presence] in Serum
11
51
2.54
1.67
1.4
1.6
—
—
—
0
0
(3003338) MCHC [Mass/volume]
26
335
0.45
1.66
35.2
14.8
g/l
330.8
334.9
1.19
26
335
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
14
3.88
1.66
1.4
1.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
7
26
3.00
1.66
1.3
1.8
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
7
27
2.88
1.59
4.3
36.3
%
94.7
94.9
—
7
27
(3014111) Lactate [Moles/volume] in Serum or Plasma
6
21
3.14
1.56
2.8
20.1
mmol/l
1.6
1.1
—
6
21
(40768804) Tissue Pathology biopsy report
20
125
2.10
1.53
3.0
1.8
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
18
108
2.13
1.53
5.1
3.3
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
5
16
3.38
1.48
3.8
24.8
%
0.6
0.8
—
5
16
(3011288) Drugs identified in Urine by Screen method
5
16
3.38
1.48
13.2
2.9
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
0
40
0.00
1.41
0.0
1.4
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
5
17
3.18
1.40
3.6
23.5
%
1.1
2.4
—
5
17
(3002173) Hemoglobin [Mass/volume] in Arterial blood
6
24
2.73
1.35
4.7
31.2
g/l
122.2
128.5
—
6
24
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
12
64
2.20
1.34
1.8
1.7
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
8
36
2.49
1.32
1.5
1.6
—
—
—
0
0
(3019060) Gas panel - Arterial blood
5
19
2.83
1.25
3.8
28.1
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
13
74
2.07
1.23
1.8
2.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
6
26
2.51
1.23
3.8
3.6
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
10
51
2.24
1.22
1.9
1.5
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
19
126
1.89
1.18
4.3
3.0
mmol/l
2.4
2.4
0.04
19
107
(3044889) 12 lead EKG panel
30
233
1.90
1.12
4.5
3.1
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
14
87
1.89
1.03
5.1
3.3
e6/l
0.9
0.3
0.32
14
64
(36304419) Bacteria [Presence] in Urine
14
87
1.89
1.03
5.1
3.2
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
6
27
2.41
0.98
3.2
7.7
mmol/l
24.6
25.1
—
6
27
(3017446) Testosterone [Moles/volume] in Serum or Plasma
6
30
2.15
0.91
2.8
2.7
nmol/l
10.8
15.2
—
6
30
(3012095) Magnesium [Moles/volume] in Serum or Plasma
10
58
1.94
0.88
2.8
7.0
mmol/l
0.8
0.8
—
10
52
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
6
31
2.08
0.88
1.2
1.4
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
6
33
1.94
0.82
1.8
1.4
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
9
53
1.87
0.82
1.6
2.9
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
15
102
1.71
0.81
5.4
3.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
22
168
1.62
0.77
4.3
4.8
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
18
132
1.62
0.73
6.3
3.4
—
—
—
0
0
(3000492) Spirometry study
7
42
1.79
0.72
1.1
1.3
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
7
42
1.79
0.72
2.0
1.4
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
14
97
1.65
0.70
5.1
3.4
e6/l
40.7
41.8
0.01
14
75
(40760892) CBC W Ordered Manual Differential panel - Blood
13
89
1.65
0.68
14.7
6.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
0
19
0.00
0.62
0.0
1.4
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
21
166
1.51
0.59
5.7
3.3
estimate
0.0
0.0
—
10
33
(3035350) Ketones [Presence] in Urine by Test strip
21
166
1.51
0.59
5.7
3.2
estimate
0.0
0.0
—
10
33
(3026008) Bacteria identified in Urine by Culture
14
101
1.57
0.59
4.4
2.4
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
37
334
1.68
0.58
6.1
4.7
mu/l
1.9
1.9
0.03
37
311
(3021601) Nitrite [Presence] in Urine by Test strip
21
167
1.49
0.57
6.0
4.3
estimate
0.0
0.0
—
10
35
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
16
120
1.52
0.57
3.2
4.0
ng/l
23.3
23.8
0.02
11
79
(40768797) Stomach Pathology biopsy report
6
39
1.62
0.55
1.7
1.3
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
15
115
1.46
0.47
2.2
2.5
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
5
32
1.63
0.44
1.8
1.6
u/l
40.2
29.7
—
5
25
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
8
60
1.41
0.43
2.6
3.4
mmol/l
2.5
2.5
—
8
52
(3000330) Specific gravity of Urine by Test strip
0
15
0.00
0.42
0.0
1.9
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
6
42
1.49
0.37
12.8
4.8
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
10
74
1.45
0.36
1.3
1.3
iu/ml
41.6
37.1
—
5
29
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
6
45
1.38
0.35
5.2
4.7
%
29.7
29.3
—
6
25
(3013512) EKG study
13
104
1.35
0.31
3.1
3.9
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
5
37
1.40
0.24
1.8
2.2
—
—
—
0
0
(3015736) pH of Urine
15
127
1.27
0.24
4.3
3.0
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.2
—
6.3
—
0
6
(4034850)
0
11
0.00
0.21
0.0
7.4
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
0
11
0.00
0.21
0.0
1.6
—
160.8
—
0
5
(3008037) Lactate [Moles/volume] in Venous blood
0
11
0.00
0.21
0.0
1.4
—
1.4
—
0
11
(1761482) Bacteria [#/volume] in Urine by Culture
0
11
0.00
0.21
0.0
3.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(1002224) Polysomnography panel
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
29
268
1.24
0.20
2.6
3.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
12
102
1.24
0.17
1.8
1.5
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
38
365
1.30
0.17
28.4
16.0
mmol/l
139.8
139.9
0.05
38
359
(3009508) Creatinine [Moles/volume] in Urine
12
103
1.23
0.16
6.4
2.8
mmol/l
5.6
7.8
2.39
12
83
(3009542) Hematocrit [Volume Fraction] of Blood
36
345
1.24
0.15
23.8
13.2
%
40.7
40.4
0.18
24
272
(1761868) Lipid panel - Serum or Plasma
11
124
0.85
0.10
3.0
2.6
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
5
46
1.10
0.10
1.0
1.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
6
53
1.15
0.09
1.0
1.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
6
55
1.11
0.09
1.0
1.9
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
38
369
1.22
0.08
29.8
15.9
mmol/l
4.0
4.0
0.31
38
362
(3011397) Hemoglobin [Presence] in Urine by Test strip
8
73
1.12
0.08
4.8
3.1
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
10
89
1.16
0.07
2.2
2.6
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
33
319
1.14
0.07
4.1
5.3
mmol/mol
37.1
39.5
1.14
28
294
(3024928) Oxygen saturation in Venous blood
0
7
0.00
0.00
0.0
8.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
6
61
0.98
0.00
1.0
2.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
39
384
1.14
0.00
25.5
11.3
—
—
—
0
0
(4094501)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
0
7
0.00
0.00
0.0
1.0
—
93.3
—
0
7
(3052851) Hemolysis interference index of Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4146454)
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
0
6
0.00
0.00
0.0
25.7
—
6.0
—
0
6
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
0.4
—
0
6
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
9
89
1.01
0.00
1.4
1.8
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
0
6
0.00
0.00
0.0
1.3
—
4.0
—
0
6
(3035285) Chloride [Moles/volume] in Venous blood
0
6
0.00
0.00
0.0
1.3
—
105.7
—
0
6
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.4
—
3.4
—
0
8
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
1.9
—
0
6
(3002523) Influenza virus A Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
0
6
0.00
0.00
0.0
6.7
—
71.4
—
0
6
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
5
52
0.96
0.00
2.0
1.4
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
15.5
—
0
5
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
0
9
0.00
-0.00
0.0
1.4
—
7.4
—
0
9
(3023511) Choriogonadotropin [Units/volume] in Urine
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint D3_HISTICYTSDROTH and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have D3_HISTICYTSDROTH.

N-year risk Females Males
1 No data No data
5 No data No data
10 No data No data
15 No data No data
20 No data No data

Relationships between endpoints

Index endpoint: D3_HISTICYTSDROTH – Other histiocytosis syndromes

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data